Maurizio Voi Selected Research

Hypercholesterolemia

10/2016

Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maurizio Voi Research Topics

Disease

14	Neoplasms (Cancer) 01/2019 - 09/2002
6	Tuberous Sclerosis (Bourneville's Disease) 10/2018 - 10/2016
4	Seizures (Absence Seizure) 10/2018 - 10/2016
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2018 - 11/2016
4	Renal Cell Carcinoma (Grawitz Tumor) 12/2017 - 03/2016
3	Disease Progression 11/2016 - 04/2005
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2013 - 12/2004
2	Hyperglycemia 01/2018 - 10/2016
2	Infections 01/2018 - 03/2016
2	Stomatitis 01/2018 - 03/2016
2	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2018 - 01/2017
2	Angiomyolipoma 01/2018 - 01/2017
2	Breast Neoplasms (Breast Cancer) 10/2016 - 01/2004
2	Exanthema (Rash) 04/2005 - 12/2004
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Hemorrhage 01/2017
1	Primitive Neuroectodermal Tumors (PNET) 01/2017
1	Flank Pain 01/2017
1	Hypercholesterolemia 10/2016
1	Fatigue 03/2016
1	Hepatocellular Carcinoma (Hepatoma) 01/2016
1	Hepatitis B 01/2016
1	Pericarditis 10/2014
1	Stomach Neoplasms (Stomach Cancer) 06/2013
1	Leukemia 10/2009
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2008
1	Hypersensitivity (Allergy) 04/2005
1	Febrile Neutropenia 04/2005
1	Diarrhea 04/2004
1	Nausea 04/2004
1	Renal Insufficiency (Renal Failure) 04/2004
1	Vomiting 04/2004

Drug/Important Bio-Agent (IBA)

15	Everolimus FDA Link 10/2018 - 01/2016
5	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2016
3	TOR Serine-Threonine KinasesIBA 01/2017 - 10/2016
2	trans-sodium crocetinate (crocetin)IBA 10/2018 - 01/2018
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018 - 10/2016
2	Sunitinib (Sutent)FDA Link 01/2017 - 03/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 01/2016
2	7- (4- (3- ethynylphenylamino)- 7- methoxyquinazolin- 6- yloxy)- N- hydroxyheptanamideIBA 10/2014 - 06/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 04/2005 - 12/2004
2	Matrix Metalloproteinase InhibitorsIBA 04/2005 - 12/2004
2	N-((2S)-2-mercapto-1-oxo-4-(3,4,4- trimethyl- 2,5- dioxo- 1- imidazolidinyl)butyl)- L- leucyl- N,3- dimethyl-L-ValinamideIBA 04/2005 - 12/2004
2	Carboplatin (JM8)FDA LinkGeneric 04/2005 - 12/2004
2	7- cyano- 2,3,4,5- tetrahydro- 1- (1H- imidazol- 4- ylmethyl)- 3- (phenylmethyl)- 4- (2- thienylsulfonyl)- 1H- 1,4- benzodiazepine (BMS 214662)IBA 04/2005 - 04/2004
1	dabrafenibIBA 01/2019
1	trametinibIBA 01/2019
1	Chromogranin AIBA 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2019
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2019
1	lipoarabinomannan (LAM)IBA 01/2018
1	pazopanib FDA Link 12/2017
1	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 01/2017
1	GastrinsIBA 01/2017
1	Glucagon (Glukagon)FDA Link 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Cell-Free Nucleic AcidsIBA 10/2016
1	Estrogens (Estrogen)FDA Link 10/2016
1	LigandsIBA 10/2016
1	Estrogen ReceptorsIBA 10/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	CreatinineIBA 10/2014
1	Cadherins (E-Cadherin)IBA 06/2013
1	Histone Deacetylases (Histone Deacetylase)IBA 08/2012
1	Histone Deacetylase InhibitorsIBA 08/2012
1	CUDC-907IBA 08/2012
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 08/2012
1	Dasatinib (BMS 354825)FDA Link 10/2009
1	Phosphotransferases (Kinase)IBA 01/2008
1	src-Family KinasesIBA 01/2008
1	pipoxolan (BR 18)IBA 04/2005
1	Farnesyltranstransferase (Farnesyltransferase)IBA 04/2005
1	Matrix Metalloproteinases (MMPs)IBA 12/2004
1	Transaminases (Aminotransferases)IBA 04/2004
1	Cisplatin (Platino)FDA LinkGeneric 04/2004
1	TransferasesIBA 04/2004
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2004
1	tesmilifene (DPPE)IBA 01/2004
1	taxaneIBA 09/2002
1	7-methylthiomethylpaclitaxel (BMS 184476)IBA 09/2002

Therapy/Procedure

6	Therapeutics 10/2018 - 04/2004
3	Nephrectomy 12/2017 - 01/2017
2	Drug Therapy (Chemotherapy) 04/2005 - 12/2004
1	Duration of Therapy 10/2016
1	Premedication 09/2002